Behavioral-psychology weight-loss app now bundled with GLP-1 prescriptions via Noom Med
Noom is a New York-based behavioral-psychology weight-loss app founded in 2008 by Saeju Jeong and Artem Petakov, best known for pairing CBT-style coaching with calorie and habit tracking. The 2021 Series F led by Silver Lake (with Sequoia and Temasek) valued the company at $3.7B on $540M of fresh capital — the high-water mark. In 2024 Geoff Cook succeeded Saeju Jeong as CEO and pivoted Noom into the GLP-1 wave via Noom Med, bundling behavioral coaching with semaglutide/tirzepatide prescription telehealth, which has become the company's fastest-growing surface as Ozempic and Mounjaro adoption explode.
Health Tech📍 New York, NYFounded 2008
Current Valuation
$3.7B
as of 2024-Q2
UNICORN
QL Price
$3.7B
0% vs last round
QuantLogix's current estimate for Noom, published 2026-10-07 — in line with the last disclosed round of $3.7B (2024-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$3.7B
2024-Q2
weight 0.21
Secondary market print
$3.7B
2026-06-27
weight 0.54
How this price has held up
No round has priced for Noom since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-07 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Noom, 2026-10-07 (3933c76c76f83bcf).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookrumored
Is Noom going public?
An IPO is rumored, with nothing filed. Noom remains private and the date is not the company's.
What is Noom's valuation in 2026?
Noom is valued at $3.7B as of 2024-Q2, set by its Series F ($540M, May 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Noom filed an S-1?
No public S-1 is on file for Noom as of 10/07/2026; the IPO is rumored.
Who are Noom's investors?
Noom's investors include Silver Lake, Sequoia Capital, Temasek, RRE Ventures, Oak HC/FT, Samsung Ventures and 1 more.
How much has Noom raised?
Noom has raised $624M in total, most recently a Series F of $540M in May 2021.
Is Noom publicly traded — can you buy Noom stock?
No. Noom is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Noom on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Geoff Cook
Founded
2008
HQ
New York, NY
Employees
~1000
Total Raised
$624M
Est. Revenue
$1.0B (2023)
Growth
~25% growth in 2023 to ~$1B revenue; pivoted to Noom Med (GLP-1 prescription telehealth) under new CEO Geoff Cook in 2024
Last Round
Series F — $540M (May 2021) · Lead: Silver Lake
IPO Status
rumored
Fundraising Status
Series F · $540M · 5y 5mo ago
rumoredTotal raised $624M
Secondary Market
Implied price / share
$2.98
Open interest
3
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. The feed’s last-round price for this company is not a plausible per-share figure, so no comparison is shown. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$540M
May 2021
Silver Lake
—
Talent Signal
Hiring trend
▲ Hiring uptrend
+33% vs 2026-08
Open roles
12
via careers page
Product-build share
42%
engineering, research, product, design
Trajectory
scaling
balanced build + GTM — 42% builders vs 58% go-to-market/G&A — scaling both sides.
Executive bench growing while hiring expands: 1 senior hire (CFO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INJim BugdenCFO · 2026-09-10
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Director of Product Design, Noom Med\<br>\<br>Princeton, New Jersey, United StatGrowth Product Manager (Builder)\<br>\<br>Princeton, New Jersey, United StatesAgentic Engineer (New Grad)\<br>\<br>Princeton, New Jersey, United StatesStaff Software Engineer\<br>\<br>Princeton, New Jersey, United StatesProduct Management, Design & ResearchSkip to content
Counted from Noom's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Saeju JeongArtem Petakov
Investors
Silver Lake · Sequoia Capital · Temasek · RRE Ventures · Oak HC/FT · Samsung Ventures · Serena Ventures
Products
Noom Weight (behavioral CBT app for weight loss)
Noom Med (GLP-1 prescription telehealth)
Noom for Diabetes
Noom Mood (mental wellness)
Noom Family
Competitors
WW International (WW) · Hims & Hers Health (HIMS) · Ro · Calibrate · Found · Eli Lilly Direct (LLY)
TelehealthGLP-1Weight LossConsumer HealthBehavioral Health
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q2. Refreshed quarterly.